Planejamento de carreira

O presente trabalho tem o objetivo a realização de um plano de carreira a curto, médio e longo prazo, a partir de, estudos bibliográficos desempenhados em sala de aula e através de entrevistas feitas com o supervisor do estágio e com uma funcionária pública, com o intuito de ser ter uma visão mais ampla da área e escolhida para desenvolver o plano de carreira

Estudo da estabilidade do complexo ácido fítico e o íon Ni(II) Study of stability of phytic acid with Ni(II) complex

A técnica de titulação potenciométrica foi utilizada para verificar as propriedades ácida-base do ácido fítico [1,2,3,4,5,6-hexaquis(dihidrogenofosfato)-mio-inositol] e do complexo ácido fítico e Ni(II), em solução aquosa, em temperatura e força iônica constantes. Para avaliar o comportamento térmico e a complexação do ácido fítico com o íon Ni(II) foram realizadas análises de Termogravimetria (TG), Termogravimetria Derivada (DTG), Calorimetria Exploratória Diferencial (DSC) e estudos de Espectrofotometria de Infravermelho. Foram obtidas oito constantes de protonação da amostra de ácido fítico na forma de sal de dipotássio e sete constantes de estabilidade do complexo ácido fítico e Ni(II). As reações de protonação e de formação ocorrem na faixa de pH de 2,0 a 11,0. Os dados obtidos mostram que o ácido fítico encontra-se totalmente deprotonado em pH 12,0 no qual a espécie ML (um ligante para um íon metálico) encontra-se totalmente formada no mesmo valor de pH. Os resultados obtidos por TG e DSC revelaram tanto para o ácido fítico como para o complexo boa estabilidade até a temperatura próxima a 200ºC. Por TG, DTG e DSC conclui-se também que a estequiometria do complexo estudado foi de um mol de ligante para um mol de íon metálico. A Espectrofotometria de Infravermelho comprovou a estabilidade do ácido fítico e a sua interação com o íon Ni(II).<br>The technique of potenciometric titration was used to verify the acid-basic properties of the phytic acid, [1,2,3,4,5,6-hexakis(dihydrogen phosphate)-myo-inositol] and the Phytic Acid-Ni(II) complex, in aqueous solution, in constant temperature and ionic strength. To evaluate the thermal behavior end complexation of the isolated phytic acid with the Ni(II) were performed analyses of thermogravimetry (TG), calorimetric scanning differential (DSC) and studies Spectroscopy Infrared (IR). Eight protonation constants of the phytic acid sample as dipotassium salt were determined and seven complex stabilization constants Phytic Acid-Ni(II) sample. The protonation and formation reactions occur within a pH of 2.0 and 11.0. The data obtained show that the phytic acid is totally deprotonate at pH 12.0. The result also shows that the ML species of the complex (one ligand and one metal ion) it totally meets formed in you same value of pH. TG, DTG and DSC techniques reveal that phytic acid as well as the complex had good stability up to 200ºC. The obtained data permitted establish the stoichiometry 1:1 of this complex in the solid state. The Spectroscopy Infrared (IR) proved the stability of the phytic acid and it's interaction with Ni(II)

Equilibrium, Thermoanalytical and Spectroscopic Studies to Characterize Phytic Acid Complexes with Mn(II) and Co(II)

Estudos potenciométricos foram realizados para determinar o grau de ligação do ácido fítico com os íons Co(II) e o Mn(II), na ausência de dioxigênio. As constantes de equilíbrio para as principais espécies formadas são relatadas, e os resultados são representados na forma de diagramas de distribuição mostrando a concentração individual dos complexos como uma função do pH. , was totally formed at pH 7.0 and the complexes were synthesized from this data. A solid state complex of Mn(II) and Co(II) with phytic acid was synthesized. Thermogravimetry, differential scanning calorimetry, and infrared spectroscopy were used to investigate and characterize the thermal behavior of these compounds. The results led to information on the composition, dehydration, thermal stability and thermal decomposition of the isolated complexes

Equilibrium, thermoanalytical and spectroscopic studies to characterize phytic acid complexes with Mn(II) and Co(II)

Potentiometric studies were carried out to determine the binding degree of phytic acid with Co(II) and Mn(II) ions, in the absence of dioxygen. Equilibrium constants for all major complexes formed are reported, and the results are presented in the form of distribution diagrams showing the concentrations of individual complexes as a function of pH. The formation constants of the complexes show higher values for the species in which the ligand was more deprotonated. Potentiometric data indicates that the species [MH(4)L](6-), was totally formed at pH 7.0 and the complexes were synthesized from this data. A solid state complex of Mn(II) and Co(II) with phytic acid was synthesized. Thermogravimetry, differential scanning calorimetry, and infrared spectroscopy were used to investigate and characterize the thermal behavior of these compounds. The results led to information on the composition, dehydration, thermal stability and thermal decomposition of the isolated complexes

LOPH and D-MHC in the Treatment of FeLV Associated Acute Leukemia in a Cat

Background: Bone marrow primary malignancies are denominated leukemias, classified as myeloid or lymphoid, according to the cell lineage, and acute or chronic, according to the cell´s state of maturation. In cats, acute lymphoid leukemia is the most common form, especially in regions endemic for feline leukemia virus and / or feline immunodeficiency virus. A new treatment protocol for lymphomas, called LOPH, has been described for animals with FeLV persistent viremia. This study aimed to report a case of a cat presenting with FeLV associated acute leukemia and treated with the LOPH protocol, and, in the rescue phase, a modification of the D-MAC protocol, denominated D-MHC.Case: A 4-year-old mixed breed intact queen was attended due to lethargy and inappetence. The patient did not present any relevant abnormalities in the clinical exam and complementary exams were performed including complete blood count, biochemical profile, SNAP Feline Triple Test, chest radiographs and abdominal ultrasound. Imaging tests and biochemical values were unremarkable, but the patient presented a reagent result for FeLV and severe leukocytosis due to lymphocytosis. The morphological evaluation of the blood smear revealed the presence of blasts, in a concentration greater than 20% of the nucleated cells, which allowed the characterization of a leukemic state, probably lymphoid. First-line treatment was based on the LOPH protocol, including Lomustine, Vincristine, Prednisoloneand Doxorubicin, in four-week cycles. Nevertheless, during the third cycle, 66 days after the institution of this protocol, the patient presented a febrile condition along with marked leukocytosis due to lymphocytosis, confirming leukemia recurrence. A rescue attempt was performed with a modification of the D-MAC protocol, originally consisting of the combination of dexamethasone, melphalan, actinomycin-D and cytarabine, but with replacement of actinomycin-D by doxorubicin, and therefore nominated D-MHC. After the three cycles there was a return of the febrile condition associated with severe pancytopenia and euthanasia was elected due to poor clinical condition, resulting in a survival time of 124 days. The hematological toxicity of the induction protocol included anemia and neutropenia, with mainly grade I events, but with the occurrence of a grade IV event. The adverse effects of the rescue protocol were similar, but with a greater number of grade IV events.Discussion: FeLV is considered the most lethal retrovirus of the domestic cat, with a major impact on health and life expectancy. Persistent FeLV antigenemia increases the risk of hematopoietic neoplasms in 62.1 times due to a direct insertional mutagenesis. In endemic regions, approximately 70% of cats with acute leukemia have persistent FeLV antigenemia, as the patient in this report. The diagnosis was made through association of retroviral status and the identification of more than 20% of blasts, possibly lymphoblasts, in the blood stream, sparing the need for a myelogram. Considering the poor prognosis for acute lymphoid leukemias and the patient's retroviral status, treatment was initiated with the LOPH protocol, including lomustine, as a potent agent to induce remission, and doxorubicin, which can result in longer remission intervals. After 66 days free of the disease, the patient presented recurrence of the leukemic condition, starting the rescue protocol D-MHC. Remission was again obtained with duration similar to the first protocol, however, on the occasion of a new leukemia recurrence, euthanasia was elected. The treatment adopted for the patient in this report resulted in a longer survival time than reported in other studies. Despite the aggressiveness of the protocols, especially the D-MHC, it was possible to perform it using the monocyte and granulocyte stimulation factor to reverse neutropenia